ATAI
ATAI Life Sciences BV
NASDAQ: ATAI · HEALTHCARE · BIOTECHNOLOGY
$4.12
-4.85% today
Updated 2026-04-29
Market cap
$1.51B
P/E ratio
—
P/S ratio
369.70x
EPS (TTM)
$-2.91
Dividend yield
—
52W range
$1 – $7
Volume
6.2M
ATAI Life Sciences BV (ATAI) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-88.6%
Last 4 quarters
Revenue YoY growth
-21420.0%
Most recent quarter
EPS YoY growth
-620.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-5.4%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-6.8%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-26 | $-1.73 | -1552.3% | $3.54 | $3.35 | -5.4% |
| 2025-11-12 | $-0.28 | -154.5% | $4.43 | $4.13 | -6.8% |
| 2025-08-14 | $-0.14 | -16.7% | $4.05 | $3.88 | -4.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.10 | $-1.73 | -1552.3% | $1.07M | -21420.0% |
| 2025-09-30 | $-0.11 | $-0.28 | -154.5% | $749000.00 | +1772.5% |
| 2025-06-30 | $-0.12 | $-0.14 | -16.7% | $719000.00 | +163.4% |
| 2025-03-31 | $-0.18 | $-0.15 | +16.7% | $1.55M | — |
| 2024-12-31 | $-0.15 | $-0.24 | -60.0% | $-5000.00 | -127.8% |
| 2024-09-30 | $-0.16 | $-0.16 | +0.0% | $40000.00 | -54.0% |
| 2024-06-30 | $-0.16 | $-0.36 | -125.0% | $273000.00 | +58.7% |
| 2024-03-31 | $-0.18 | $-0.17 | +5.6% | — | — |
| 2023-12-31 | $-0.16 | $-0.12 | +25.0% | $18000.00 | — |
| 2023-09-30 | $-0.20 | $-0.28 | -40.0% | $87000.00 | — |
| 2023-06-30 | $-0.21 | $-0.21 | +0.0% | $172000.00 | — |
Frequently asked questions
Has ATAI Life Sciences BV beaten earnings estimates?
ATAI Life Sciences BV has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -88.6% over the last 4 quarters.
How does ATAI stock react to earnings?
ATAI stock has moved an average of -5.4% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is ATAI Life Sciences BV's revenue growth rate?
ATAI Life Sciences BV reported year-over-year revenue growth of -21420.0% in its most recent quarter, with EPS growing -620.8% year-over-year.